| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6116735 | Human Immunology | 2013 | 8 Pages |
Abstract
Based on these results, HLA-G may be a candidate biomarker to evaluate early prognosis and disease activity in ERA patients.
Keywords
Disease Activity Score-28KIR2DL4MoAbESRDAS28EACHLA-GDMARDsTNF-alphaACPAACREarly rheumatoid arthritisEarly arthritisRheumatoid arthritisMonoclonal antibodyGlobal healthtumor necrosis factor-alphadisease-modifying anti-rheumatic drugserythrocyte sedimentation rateCoefficient of Variationrheumatoid factorERAconfidence intervalPower Dopplerodds ratiopolymerase chain reactionPCRAnti-cyclic citrullinated peptideAmerican College of Rheumatology
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Roberta Rizzo, Ilaria Farina, Daria Bortolotti, Elisa Galuppi, Antonella Rotola, Loredana Melchiorri, Giovanni Ciancio, Dario Di Luca, Marcello Govoni,